It is time for the FDA to re-evaluate metrics for weight loss drugs

Between 2013 and 2016, 49.1 percent of U.S. adults surveyed had attempted to lose weight within the last 12 months. Weight loss medications have reached the public eye in popular culture and practice. To be considered effective in a clinical trial by the FDA, the drug candidate must demonstrate a statistically significant difference in mean Read more… It is time for the FDA to re-evaluate metrics for weight loss drugs originally appeared in KevinMD.com.